Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Innovative Guard Helps Prevent Needlestick Injuries

By HospiMedica International staff writers
Posted on 24 Apr 2018
Intuitive ergonomic design and patented safety features increase staff security following retraction of arteriovenous fistula (AVF) dialysis needles.

The NxStage Medical (Lawrence, MA, USA) MasterGuard Plus needles are designed with a patented FingerShield anchor that provides a barrier between the pressure-holding fingers and the sharp tip of the needle. During needle retraction, flexible wings with interlocking grips are drawn backwards into the jaw; the small jaw and rigid base of the MasterGuard plus align the needle into the center of the guard. Once the needle is fully retracted, an audible click is heard, signifying that the needle is locked in a steep rear angle that prevents accessibility.

The MasterGuard plus needles themselves also offer several new features that allow for easier insertion, including ultra-thin walls; precisely ground bevels and a siliconized tip for smooth cannulation; a short hub designed to minimize leverage; and a rotatable bevel indicator that reduces the risk of potential tissue damage associated with unwarranted rotation of fixed wing needles.

“Early customer feedback has been very positive, validating many of the benefits we expected,” said Joseph Turk, president of NxStage Medical. "We are very excited to bring these enhanced features to dialysis staff and patients, while maintaining the ease of use that they have come to expect from Medisystems products.”

“I’ve been working in hemodialysis for 40 years, and I’ve seen every hemodialysis needle safety device that’s come along,” said Joe Atkins, RN, MBA, of Sidney (OH, USA). “I can safely say that, for all the right reasons, including safety and ease of cannulation, MasterGuard Plus is my first and only choice. I wouldn’t use anything else.”

An AVF is the most recommended access for kidney disease patients undergoing dialysis, created by connecting a patient's vein and artery to form a long-lasting site through which blood can be removed and returned. After the creation of an AVF, blood flow increases immediately, reaching 700–1,000 mL/min within one month. Both the artery and the vein dilate and elongate in response to the greater blood flow and shear stress, but the vein dilates more; when large enough to allow cannulation, the AVF is defined as mature.

Related Links:
NxStage Medical


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Suction Electrode System
Strässle
New
Patient Monitor
Vista 300
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The Trilogy Valve with locator technology is the only TAVI system approved for aortic regurgitation (Photo courtesy of JenaValve)

New Transcatheter Valve Found Safe and Effective for Treating Aortic Regurgitation

Aortic regurgitation is a condition in which the aortic valve does not close properly, allowing blood to flow backward into the left ventricle. This results in decreased blood flow from the heart to the... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.